content

Takeda to Manufacture and Provide 150 Million Doses of Novavax COVID-19 Vaccine Candidate to the Government of Japan

Takeda Pharmaceutical Company Limited announced that the Government of Japanโ€™s Ministry of Health, Labour and Welfare (MHLW) will purchase 150 million doses of Novavaxโ€™...

Berrys Vistop Meets Growing Sustainability and Sterilization Demands

Following the International Sustainability and Carbon Certificate (ISCC) Plus accreditation of its Berry Astra Plastique facility in Saint-Georges-de-Reneins, France, Berry Healthcareโ€™s market-leading Vistopยฎ PP36...

Genezen Appoints New CEO as GMP Expansion Begins

Genezen Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has appointed Ray Kaczmarek as CEO. Mr. Kaczmarek has over 28 years...

CEVEC and UCB sign agreement for the use of CEVEC’S ELEVECTA AAV manufacturing technology in Gene Therapy

CEVEC Pharmaceuticals GmbH announced the signing of an agreement with UCB S.A. on the evaluation and use of CEVECโ€™s proprietary ELEVECTAยฎ Technology for the...

LTO Network and Sphereon Partner With Triall for World’s First Application of Blockchain Technology to COVID-19 Clinical Trials

Dutch blockchain companies LTO Network and Sphereon have partnered with Triall, experts in the realm of blockchain and clinical research, to deliver the first...

Arecor Therapeutics Signs Formulation Agreement with Intas Pharmaceuticals

Arecor Therapeutics plc, a biopharmaceutical group advancing therapies to enable healthier lives, has signed a formulation agreement with Intas Pharmaceuticals Ltd. Under this agreement, Arecor...

SkyCell partners with All Nippon Airways to support Japanese pharma market

At SkyCell, we have expanded our airline partnerships into Japan by partnering with All Nippon Airways (ANA), the countryโ€™s largest airline. This collaboration will...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read